The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia
Open Access
- 25 March 2011
- journal article
- research article
- Published by Springer Nature in Blood Cancer Journal
- Vol. 1 (3) , e12
Abstract
Nuclear factor-κB (NF-κB) is an important regulator of cell survival and has been shown to be constitutively active in chronic lymphocytic leukemia (CLL) cells. Recently, a novel NF-κB inhibitor, IMD-0354 (N-(3, 5-bis-trifluoromethyl-phenyl)-5-chloro-2-hydroxy-benzamide), was shown to specifically inhibit the phosphorylation of IκBα by IkB kinases, thus preventing NF-κB release. In this study, we investigated if IMD-0354 can inhibit NF-κB activation and induce apoptosis in CLL cells in vitro. The rate of increase in apoptosis, drug sensitivity and DNA-binding activity of NF-κB were studied using Annexin V stainings, the fluorometric microculture cytotoxicity assay and electrophoretic mobility shift assay, respectively. Finally, the impact of IMD-0354 treatment on the expression of a set of apoptosis-related genes was investigated. The results clearly show that IMD-0354 induced apoptosis (mean 26%, range 8–48%) in CLL cells, independent of immunoglobulin heavy variable (IGHV) gene mutational status, and showed a dose-dependent cytotoxic effect. IMD-0354 treatment also significantly lowered the DNA-binding activity of NF-κB in CLL cells. In addition, we identified differences in expression levels of pro- and antiapoptotic genes following IMD-0354 treatment. In summary, our novel findings show that IMD-0354 can induce apoptosis in CLL cells, and thus merits further investigation as an anticancer agent in vivo.Keywords
This publication has 25 references indexed in Scilit:
- NF-κB as a therapeutic target in chronic lymphocytic leukemiaExpert Opinion on Therapeutic Targets, 2010
- Effectiveness of IκB kinase inhibitors in murine colitis-associated tumorigenesisJournal of Gastroenterology, 2009
- Fludarabine in the treatment of chronic lymphocytic leukemia: a reviewTherapeutics and Clinical Risk Management, 2009
- State-of-the-art treatment of chronic lymphocytic leukemiaHematology-American Society Hematology Education Program, 2009
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Pro-Apoptotic PUMA and Anti-Apoptotic Phospho-BAD Are Highly Expressed in Colorectal CarcinomasDigestive Diseases and Sciences, 2007
- Cell DeathCell, 2004
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Detection of tumor‐specific cytotoxic drug activity IN VITRO using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patientsInternational Journal of Cancer, 1994
- Spontaneous programmed death (apoptosis) of B‐chronic lymphocytic leukaemia cells following their culture in vitroBritish Journal of Haematology, 1989